T1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study.

Source:http://linkedlifedata.com/resource/pubmed/id/15510979

Download in:

View as

General Info

PMID
15510979